PGIM Jennison Global Infrastructure Fund reported an 18.42% return for 2025, driven by strong utility performance. Read the full analysis for more details.

DUMFRIES, VA, March 12, 2026 (EZ Newswire) -- Mainspring Recovery, opens new tab, a Virginia-based addiction treatment provider, says its clinical leadership is closely monitoring the evolving ...

Mainspring Recovery, opens new tab, a Virginia-based addiction treatment provider, says its clinical leadership is closely monitoring the evolving overdose landscape and will continue sharing insights ...

Tax scams are evolving from unemployment fraud to viral tax hacks. Learn the IRS warnings for 2026 and how to protect your return.

State health officials have launched a system aimed at allowing the public track how local governments spend the almost $1 billion in opioid settlement funds they expect to receive by 2039.

Most executives understand that bad training data can compromise the AI output, but many don't understand how to identify or address this issue.

WHOOP, the human performance company, today unveiled multiple initiatives and new clinically-backed features, including the coming launch of the company’s ...

Beyond recovery tools, Longevity Based offers a wide range of the best biohacking devices used across health, fitness, and aesthetic wellness. These include cold plunge systems, saunas, PEMF mats, ...

See discounted SaaS recovery plays after the 2026 “SaaS-pocalypse”: Intuit, Salesforce, Microsoft, Adobe & Zeta. Click for more on INTU, CRM, MSFT, ADBE and ZETA.

Ruchir Sharma, chairman of Rockefeller International and founder of Breakout Capital, laid out a clear historical pattern on live television as markets reacted to the outbreak of the Iran conflict: ...

Context Blood flow-restricted resistance exercise (BFR-RE) is used to elicit hypertrophy and strength adaptations with low external loads, making it attractive for clinical and rehabilitative ...

New phase 4 data from Vertex Pharmaceuticals revealed that more than 90% of patients recovering from aesthetic or reconstructive surgery remained opioid-free when treated with Journavx (suzetrigine) ...